Gotowa bibliografia na temat „Antidepressant medication”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Antidepressant medication”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Antidepressant medication"
Adhikari, Kamala, Scott B. Patten, Sangmin Lee i Amy Metcalfe. "Adherence to and Persistence with Antidepressant Medication during Pregnancy: Does It Differ by the Class of Antidepressant Medication Prescribed?" Canadian Journal of Psychiatry 64, nr 3 (25.09.2018): 199–208. http://dx.doi.org/10.1177/0706743718802809.
Pełny tekst źródłaAntimisiaris, Demetra, Brittany McHolan, Daniela Moga i Cortney Mospan. "Medication Related Problems". Senior Care Pharmacist 36, nr 2 (1.02.2021): 68–82. http://dx.doi.org/10.4140/tcp.n.2021.68.
Pełny tekst źródłaAntimisiaris, Demetra, Brittany McHolan, Daniela Moga i Cortney Mospan. "Medication Related Problems". Senior Care Pharmacist 36, nr 2 (1.02.2021): 68–82. http://dx.doi.org/10.4140/tcp.n.2021.68.
Pełny tekst źródłaIstilli, Plínio Tadeu, Adriana Inocenti Miasso, Cláudia Maria Padovan, José Alexandre Crippa i Carlos Renato Tirapelli. "Antidepressants: knowledge and use among nursing students". Revista Latino-Americana de Enfermagem 18, nr 3 (czerwiec 2010): 421–28. http://dx.doi.org/10.1590/s0104-11692010000300018.
Pełny tekst źródłaAdams, Nicholas Norman. "Do Newer Antidepressant Drugs Really Have Reduced Side Effects? Examining a Random “Real World” Sample of 300+ Receivers of Medications". IAFOR Journal of Psychology & the Behavioral Sciences 6, nr 1 (12.12.2020): 75–100. http://dx.doi.org/10.22492/ijpbs.6.1.05.
Pełny tekst źródłaThommasen, Harvey V., Earle Baggaley, Carol Thommasen i William Zhang. "Prevalence of Depression and Prescriptions for Antidepressants, Bella Coola Valley, 2001". Canadian Journal of Psychiatry 50, nr 6 (maj 2005): 346–52. http://dx.doi.org/10.1177/070674370505000610.
Pełny tekst źródłaViktorin, A., R. Uher, A. Reichenberg, S. Z. Levine i S. Sandin. "Autism risk following antidepressant medication during pregnancy". Psychological Medicine 47, nr 16 (22.05.2017): 2787–96. http://dx.doi.org/10.1017/s0033291717001301.
Pełny tekst źródłaMeyers, Barnett S. "Late-Life Delusional Depression: Acute and Long-Term Treatment". International Psychogeriatrics 7, S1 (październik 1995): 113–24. http://dx.doi.org/10.1017/s1041610295002390.
Pełny tekst źródłaBjørklund, Louise, Henriette Thisted Horsdal, Ole Mors, Søren Dinesen Østergaard i Christiane Gasse. "Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study". Acta Neuropsychiatrica 28, nr 2 (11.09.2015): 75–84. http://dx.doi.org/10.1017/neu.2015.52.
Pełny tekst źródłaGalbally, Megan, Andrew J. Lewis, Jarrad Lum i Anne Buist. "Serotonin Discontinuation Syndrome Following in Utero Exposure to Antidepressant Medication: Prospective Controlled Study". Australian & New Zealand Journal of Psychiatry 43, nr 9 (1.01.2009): 846–54. http://dx.doi.org/10.1080/00048670903107583.
Pełny tekst źródłaRozprawy doktorskie na temat "Antidepressant medication"
Åkerblad, Ann-Charlotte. "Adherence to Antidepressant Medication". Doctoral thesis, Uppsala University, Department of Neuroscience, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7769.
Pełny tekst źródłaNon-adherence to medication is a major obstacle in the treatment of depression. The objectives of the present study were to explore the effect of two interventions aiming to increase antidepressant treatment adherence, and to examine long-term consequences and costs of depression in adherent and non-adherent primary care patients.
A randomised controlled design was used to assess the respective effects of a written educational adherence enhancing programme and therapeutic drug monitoring in patients with major depression treated with sertraline for 24 weeks. All patients were prospectively followed during two years.
Treatment adherence was found in 41% of the 1031 included patients. None of the interventions resulted in a significant increase in adherence rate. However, significantly more patients in the group receiving the written educational material had responded at week 24 as compared to patients in the control group.
The overall remission rate after two years was 68%. In total, 34% of the responders experienced at least one relapse. Response and remission rates at week 24, year 1 and year 2 were significantly higher in adherent as compared to non-adherent patients. No relationship between adherence and relapse rate was seen.
The mean total cost per patient during two years was KSEK 363 whereof indirect costs represented 87%. No significant differences in costs between intervention groups or between adherent and non-adherent patients could be demonstrated. However, the mean cost per patient was 39% lower for treatment responders as compared to non-responders.
Non-adherence was predicted by age below 35 or above 64 years, no concomitant medications, personality disorder, sensation seeking personality traits and substance abuse.
The results indicate a strong positive relationship between treatment adherence and clinical outcome. In addition, the study shows that depression is a costly disease and that certain patient characteristics predict non-adherence.
Åkerblad, Ann-Charlotte. "Adherence to antidepressant medication /". Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7769.
Pełny tekst źródłaCotterchio, Michelle. "Antidepressant medication use and breast cancer risk". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape9/PQDD_0007/NQ41131.pdf.
Pełny tekst źródłaGallagher, Shawn Patrick, i Shawn Patrick Gallagher. "Antidepressant Medication Adherence in Active Duty Army Soldiers". Diss., The University of Arizona, 2017. http://hdl.handle.net/10150/626157.
Pełny tekst źródłaLinton, Pamela. "Correlates of Antidepressant Medication Compliance Use Among Depressed Women". DigitalCommons@USU, 2001. https://digitalcommons.usu.edu/etd/2537.
Pełny tekst źródłaSaad, Mysa. "Characteristics of Cardiorespiratory Function During Sleep Related to Depression and Antidepressant Medication Use". Thesis, Université d'Ottawa / University of Ottawa, 2019. http://hdl.handle.net/10393/39417.
Pełny tekst źródłaDimidjian, Sona. "Behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of major depression /". Thesis, Connect to this title online; UW restricted, 2005. http://hdl.handle.net/1773/9064.
Pełny tekst źródłaWeaver, Alice. "'Journeys through depression' : patients' experiences of transformational change through mindfulness based cognitive therapy (MBCT) and antidepressant medication (ADM)". Thesis, University of Exeter, 2015. http://hdl.handle.net/10871/18309.
Pełny tekst źródłaHolland, Kate E., i n/a. "Conformity and resistance: Discursive struggles in the Australian mental health field". University of Canberra. Communication, 2007. http://erl.canberra.edu.au./public/adt-AUC20081022.153830.
Pełny tekst źródłaChabenat, Apolline. "Alteration of camouflage and behaviour in two marine invertebrates, Sepia officinalis and Carcinus maenas, by antidepressant medication Hidden in the sand: Alteration of burying behaviour in shore crabs and cuttlefish by antidepressant exposure". Thesis, Normandie, 2020. http://www.theses.fr/2020NORMLH15.
Pełny tekst źródłaJuveniles of the common cuttlefish, Sepia officinalis, and the green shore crab, Carcinus maenas, develop themselves in the intertidal zone and coastal waters impacted by continental pollution such as pharmaceutical residues. This research focused on the effects two antidepressants, the fluoxetine and the venlafaxine, on the camouflage and behaviour of cuttlefish and shore crabs. Both molecules are worrying because they are designed to act on serotonergic system and are commonly detected in aquatic environments. Thus, to approach realistic scenario of exposure fluoxetine was either combined or not with venlafaxine. The results show significant effects of antidepressants at environmentally realistic concentrations, especially the combination of fluoxetine and venlafaxine, on sensitive endpoints such as burying behaviour, colour change and background matching, locomotor activity in crabs and predatory behaviour in cuttlefish. Furthermore, the exposure to antidepressants at early development stage seems to alter maturation and/or learning processes in cuttlefish. Overall, these studies demonstrated the need to investigate further with low range concentrations on key behaviours of non-target species
Książki na temat "Antidepressant medication"
Deborah, Kotz, red. The antidepressant survival program: How to beat the side effects and enhance the benefits of your medication. New York: Crown Publishers, 2000.
Znajdź pełny tekst źródłaHedaya, Robert J. The antidepressant survival guide: The clinically proven program to enhance the benefits and beat the side effects of your medication. New York: Three Rivers Press, 2001.
Znajdź pełny tekst źródłaTranquillizers and antidepressants: When to take them, how to stop. London: Sheldon, 2008.
Znajdź pełny tekst źródłaPainkillers and tranquilisers. Oxford: Heinemann Library, 2004.
Znajdź pełny tekst źródłaBadger, Frances. Medication management for people with depression in primary care. [Birmingham]: University of Birmingham, 2003.
Znajdź pełny tekst źródłaUnited States. Congress. House. Committee on Veterans' Affairs. Exploring the relationship between medication and veteran suicide: Hearing before the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Eleventh Congress, second session, February 24, 2010. Washington: U.S. G.P.O., 2010.
Znajdź pełny tekst źródłaCotterchio, Michelle. Antidepressant medication use and breast cancer risk. 1999.
Znajdź pełny tekst źródłaOrganization, World Health, red. Dose effects of antidepressant medication in different populations. Amsterdam, The Netherlands: Elsevier, 1986.
Znajdź pełny tekst źródłaWegmann, Joseph. Antidepressant Medication Strategies: We've Come a Long Way... or Have We? PESI, 2012.
Znajdź pełny tekst źródłaWegmann, Joseph. Antidepressant Medication Strategies: We've Come a Long Way... or Have We? PESI, 2012.
Znajdź pełny tekst źródłaCzęści książek na temat "Antidepressant medication"
Elsenga, S., i R. H. Van den Hoofdakker. "Antidepressant Medication and Total Sleep Deprivation in Depressives". W Neuropsychopharmacology, 639–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74034-3_63.
Pełny tekst źródłaRotem-Kohavi, Naama, Sherryl H. Goodman, Ashley Wazana i Tim F. Oberlander. "The Other Side of Prenatal Depression: Developmental Outcomes Associated with Antidepressant Medication Therapy". W Prenatal Stress and Child Development, 565–93. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-60159-1_19.
Pełny tekst źródłaTusken, Megan, Izabella Dutra de Abreu, Audrey Eichenberger, Daniela Vela i Mary “Molly” Camp. "Antidepressant Medication Augmented with Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults". W Essential Reviews in Geriatric Psychiatry, 83–86. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-94960-0_15.
Pełny tekst źródłaEarly, Maureen, Logan Wink, Craig Erickson i Christopher J. McDougle. "Antidepressant Medications". W Encyclopedia of Autism Spectrum Disorders, 187–91. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1698-3_815.
Pełny tekst źródłaAbrams, David B., J. Rick Turner, Linda C. Baumann, Alyssa Karel, Susan E. Collins, Katie Witkiewitz, Terry Fulmer i in. "Antidepressant Medications". W Encyclopedia of Behavioral Medicine, 101–3. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_1231.
Pełny tekst źródłaAkechi, Tatsuo. "Antidepressant Medications". W Encyclopedia of Behavioral Medicine, 120–21. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_1231.
Pełny tekst źródłaEarly, Maureen, Logan Wink, Craig A. Erickson i Christopher J. McDougle. "Antidepressant Medications". W Encyclopedia of Autism Spectrum Disorders, 239–43. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-91280-6_815.
Pełny tekst źródłaLeff, Julian. "A Controlled Trial of Couple Therapy versus Antidepressant Medication for Depressed Patients with a Critical Partner". W New Family Interventions and Associated Research in Psychiatric Disorders, 175–86. Vienna: Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-6148-7_10.
Pełny tekst źródłaDesai, Jignyasa. "Neuropathic Antidepressant Medications". W Pain Management and Palliative Care, 75–83. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2462-2_12.
Pełny tekst źródłaCarboni, Lucia, Chiara Piubelli i Enrico Domenici. "Proteome Effects of Antidepressant Medications". W Genomics, Proteomics, and the Nervous System, 399–441. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-7197-5_15.
Pełny tekst źródłaStreszczenia konferencji na temat "Antidepressant medication"
Delgado Rodriguez, J., L. Perez Cordon, M. Bitlloch Obiols, S. Marin Rubio, L. Campins Bernadas, V. Aguilera Jimenez, T. Gurrera Roig i M. Serra Prat. "5PSQ-072 Adequacy of antidepressant medication in elderly patients". W 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.389.
Pełny tekst źródłaHooper, Robert, i Tess Compton-Price. "CPAP Therapy improves Depressive Symptoms in OSA Patients, including those using Antidepressant Medication". W ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4143.
Pełny tekst źródłaSilva, André Douglas Marinho da, Ana Caroline Fonseca Silva, Lucas Pablo Almendro i Pedro da Cunha Dantas. "Non-epileptic seizure caused by selective serotonin reuptake inhibitors (SSRI) - case report". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.258.
Pełny tekst źródłaBrieler, Jay, Joanne Salas i Jeffrey Scherrer. "Achievement of glycemic control and antidepressant medication use in comorbid depression and type II diabetes". W NAPCRG 49th Annual Meeting — Abstracts of Completed Research 2021. American Academy of Family Physicians, 2022. http://dx.doi.org/10.1370/afm.20.s1.2902.
Pełny tekst źródłaJayasooriya, N., SK Saxena, J. Blackwell, I. Petersen, A. Bottle, MH Hotopf i RC Pollok. "P114 Changing patterns of antidepressant medication use amongst inflammatory bowel disease patients: a UK population-based study". W Abstracts of the BSG Campus, 21–29 January 2021. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2021. http://dx.doi.org/10.1136/gutjnl-2020-bsgcampus.189.
Pełny tekst źródłaKrieg, Anne K., Stefan Hess i Günter Gauglitz. "Optical sensors for therapeutic drug monitoring of antidepressants for a better medication adjustment". W SPIE Optics + Optoelectronics, redaktorzy Francesco Baldini, Jiri Homola i Robert A. Lieberman. SPIE, 2013. http://dx.doi.org/10.1117/12.2017417.
Pełny tekst źródłaRaporty organizacyjne na temat "Antidepressant medication"
Schnabel, Filipina, i Danielle Aldridge. Effectiveness of EHR-Depression Screening Among Adult Diabetics in an Urban Primary Care Clinic. University of Tennessee Health Science Center, kwiecień 2021. http://dx.doi.org/10.21007/con.dnp.2021.0003.
Pełny tekst źródłaAlmost half those on long-term antidepressants did not relapse when they stopped their medication. National Institute for Health Research, marzec 2022. http://dx.doi.org/10.3310/alert_49876.
Pełny tekst źródłaSome antidepressants can help people quit smoking, but other medications may offer greater benefits. National Institute for Health Research, lipiec 2020. http://dx.doi.org/10.3310/alert_40474.
Pełny tekst źródła